| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0011 | 1 |